methyl (Z)-7-[(1R,3R,5S)-2-[(3S)-5-cyclohexyl-3-hydroxypent-1-ynyl]-3,5-dihydroxycyclopentyl]hept-5-enoate

Names

[ CAS No. ]:
74176-31-1

[ Name ]:
methyl (Z)-7-[(1R,3R,5S)-2-[(3S)-5-cyclohexyl-3-hydroxypent-1-ynyl]-3,5-dihydroxycyclopentyl]hept-5-enoate

[Synonym ]:
Alfaprostolum
UNII-4XKL2JJ08I
Alfaprostol [USAN:BAN:INN]
5-Heptenoic acid,7-(2-(5-cyclohexyl-3-hydroxy-1-pentynyl)-3,5-dihydroxycyclopentyl)-,methyl ester,(1R-(1alpha(Z),2beta(S*),3alpha,5alpha))
Alfaprostolum [INN-Latin]
Alfaprostol
EINECS 277-746-0

Chemical & Physical Properties

[ Density]:
1.129g/cm3

[ Boiling Point ]:
573.848ºC at 760 mmHg

[ Molecular Formula ]:
C24H38O5

[ Molecular Weight ]:
406.55600

[ Flash Point ]:
189.001ºC

[ Exact Mass ]:
406.27200

[ PSA ]:
86.99000

[ LogP ]:
3.35870

[ Index of Refraction ]:
1.542

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
MJ1945000
CHEMICAL NAME :
5-Heptenoic acid, 7-(2-(5-cyclohexyl-3-hydroxy-1-pentynyl)-3,5-dihydrox ycyclopentyl)-, methyl ester, (1R-(1-alpha(Z),2-beta(S*),3-alpha,5-alpha))-
CAS REGISTRY NUMBER :
74176-31-1
LAST UPDATED :
199007
DATA ITEMS CITED :
1
MOLECULAR FORMULA :
C24-H38-O5
MOLECULAR WEIGHT :
406.62

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intramuscular
DOSE :
8333 mg/kg
SEX/DURATION :
female 16 week(s) after conception
TOXIC EFFECTS :
Reproductive - Maternal Effects - parturition
REFERENCE :
THGNBO Theriogenology. (Geron-X, Inc., P.O. Box 1108, Los Altos, CA 94022) V.1- 1974- Volume(issue)/page/year: 24,655,1985

Related Compounds

  • 2-(3-Methylphenyl)-1,1-dioxo-4-[[2-(trifluoromethyl)phenyl]methyl]-1lambda6,2,4-benzothiadiazin-3-one
  • 1-Ethyl-6-fluoro-7-(4-{[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]methyl}piperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
  • 7-{4-[5-amino-1-(4-methoxyphenyl)-1H-1,2,3-triazole-4-carbonyl]piperazin-1-yl}-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
  • 1-benzyl-4-[4-(naphthalen-1-yl)-5-sulfanylidene-4,5-dihydro-1H-1,2,4-triazol-3-yl]pyrrolidin-2-one
  • 2-[3-(1-benzyl-5-oxopyrrolidin-3-yl)-5-sulfanylidene-4,5-dihydro-1H-1,2,4-triazol-4-yl]-N-(4-fluorophenyl)acetamide
  • 2-(3,4-dimethoxyphenyl)-4-{[5-(3,5-dimethylphenyl)-1,3,4-oxadiazol-2-yl]methyl}-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-1,1,3-trione
  • 2-(5-chloro-2-methylphenyl)-4-{[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]methyl}-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-1,1,3-trione
  • 2-(3,4-dimethoxyphenyl)-4-{[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]methyl}-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-1,1,3-trione
  • 2-(5-chloro-2-methylphenyl)-4-({5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl}methyl)-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-1,1,3-trione
  • 3-{2-[(cyclobutylmethyl)(2-fluorophenyl)amino]-1,3-thiazol-4-yl}-8-methoxy-2H-chromen-2-one
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.